We find that loss or haploinsufficiency of Tgif1 accelerates leukaemia development and shortens survival time in mouse models of MLL‐AF9‐induced AML and BCR‐ABL‐induced CML. This evidence concerns the gene KMT2A and chronic myelogenous leukemia, BCR-ABL1 positive.